• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges

    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention

    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

    Tapping Functional Beverages to Meet Modern Wellness Needs

    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Florida Food Products Acquires Javo

    Roquette Launches Nutralys Rice Protein

    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy

    CTRL Launches Meal On-The-Go Bars

    GNC and RealEats Meal Delivery Partnership Expands Nationally
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Roquette Launches Nutralys Rice Protein

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development

    Study Reveals Low Intake of Tocotrienols in Polish Population

    Combination of Collagen and Boswellia Serrata Shown to Reduce Joint Discomfort

    Nutralliance Adds Eggshell-Derived Ingredients for Beauty and Joint Health to Portfolio
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Florida Food Products Acquires Javo

    Roquette Launches Nutralys Rice Protein

    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy

    CTRL Launches Meal On-The-Go Bars

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development

    Botanical Gum for Kids Aims to Curb Sugar Cravings

    Combination of Collagen and Boswellia Serrata Shown to Reduce Joint Discomfort

    Childhood Fitness and Obesity Impact Cognition Later in Life, Study Finds

    Nutralliance Adds Eggshell-Derived Ingredients for Beauty and Joint Health to Portfolio
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    JRS Pharma

    Xsto Solutions

    ESHA Research

    Atlantia Clinical Trials

    Bioactive Resources
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    JRS Pharma

    Xsto Solutions

    ESHA Research

    Atlantia Clinical Trials

    Bioactive Resources
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Capitol Comments: Reviewing Internal AER Policies

    FDA's new guidance documents and recent recalls provide some insight into its perception of a serious adverse event.

    Related CONTENT
    • Poison Control Center Reports of Kids Ingesting Melatonin Rise by 530% Since 2012
    • Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’
    • Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized
    • FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products
    • FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    Todd Harrison09.01.09
    In the June issue of Nutraceuticals World this column discussed the Hydroxycut recall. In light of that recall, and in the wake of another major recall (of Zicam homeopathic cold-remedy products), companies in the dietary supplement industry may want to consider re-evaluating their serious adverse event reporting (AER) policies.

    Serious adverse event reporting is mandatory for dietary supplements pursuant to the Dietary Supplement and Nonprescription Drug Consumer Protection Act, enacted in December 2006. This act amended the Federal Food, Drug, and Cosmetic Act to extend post-market safety reporting requirements (previously applicable only to drugs marketed under an FDA-approved application) to OTC monograph drugs and dietary supplements.

    Currently, FDA is focusing a lot of its efforts on AERs, having recently released two guidance documents-one for dietary supplements and another for monographed OTC drug products.

    FDA's AER Guidance



    According to FDA's new "Guidance For Industry: Questions and Answers Regarding Adverse Event Reporting and Recordkeeping for Dietary Supplements," an "adverse event" is "any health-related event associated with the use of a dietary supplement that is adverse." See, 21 U.S.C. 379aa-1(a)(1). More specifically, a serious adverse event is an adverse event that: "results in death, a life-threatening experience, inpatient hospitalization, a persistent or significant incapacity, or a congenital anomaly or birth defect; or requires, based on reasonable medical judgment, a medical or surgical intervention to prevent" such an outcome.

    This definition of a "serious adverse event" is limited. However, FDA has provided some further guidance and examples on the topic of serious adverse events. According to FDA, an adverse event is life-threatening if the patient is at "substantial risk of dying at the time of the adverse event or it is suspected that the use or continued use of the product would result in the patient's death." The examples of life threatening events provided by FDA include: pacemaker failures, gastrointestinal hemorrhages and bone marrow suppression.

    FDA clarifies "disability resulting from an adverse event" as meaning "significant, persistent, or permanent change, impairment, damage or disruption in the patient's body function/structure, physical activities or quality of life." FDA also notes that adverse events should be reported "if you suspect that the use of a medical product may result in a condition which require[s] medical or surgical intervention to preclude permanent impairment or damage to a patient."

    Recent Recalls



    Recent recalls and warnings issued by FDA also suggest the types of adverse events that FDA considers "serious" in the context of dietary supplements. In its letter to Iovate Health Sciences regarding the recent recall of Hydroxycut products, FDA cited liver-related adverse events as the main reason for the recall (see June "Capitol Comments" column for more detail). The agency mentioned 23 reports of liver-related incidents, ranging in severity from asymptomatic elevations in serum bilirubin levels (often indicative of impaired liver function), to acute liver failure, and one death. Importantly, FDA noted that in a "majority" of the liver-related incidents, there were no underlying risk factors for liver disease. Several of the adverse event reports described laboratory work-ups that excluded other possible causes of liver disease (such as infectious, autoimmune or metabolic causes). In addition, the agency cited four peer-reviewed published reports describing liver injuries following the consumption of Hydroxycut.

    The number and character of serious adverse liver-related event reports associated with Hydroxycut, along with the peer-reviewed reports on Hydroxycut's hepatotoxicity, and the fact that liver-related incidents were often resolved after the patient's use of Hydroxycut was discontinued, led FDA to conclude that it was very likely that exposure to Hydroxycut capsules could cause idiosyncratic hepatotoxicity. Therefore, the agency determined that Hydroxycut presented a "severe potentially life-threatening hazard to some users."

    FDA also recently supervised the recall of three Zicam products-Zicam Cold Remedy Nasal Gel, Zicam Cold Remedy Gel Swabs and Zicam Cold Remedy Swabs, Kids Size. According to the agency, it received "more than 130 reports of anosmia (loss of sense of smell, which in some cases can be long-lasting or permanent) associated with use of [the Zicam] products."

    Despite FDA's general enforcement discretion policy with regard to homeopathic products, under which FDA has set out general conditions for the marketing of homeopathic drugs without new drug approval, FDA noted that a homeopathic drug in compliance with those conditions can still be subject to enforcement action where there is evidence of a safety risk associated with the product. Ultimately, FDA determined there was a safety risk (of anosmia) associated with Zicam, and that therefore the product must have new drug approval and be labeled with adequate warnings regarding the risk of anosmia.

    Significantly, FDA noted that in addition to the 130 adverse event reports it had received directly from consumers, it had reason to believe that Matrixx Initiative had more than 800 reports related to the loss of sense of smell associated with Zicam products. FDA requested that Matrixx Initiative submit such reports to FDA if it had not already done so. The agency thereby made clear that it considered such reports to be serious adverse event reports, going on to note that "loss of sense of smell can have serious consequences. For example, patients with anosmia may not be able to detect the smell of a gas leak, smoke, or spoiled food. Loss of sense of taste can have a major impact on an individual's quality of life."

    The circumstances surrounding the Hydroxycut and Zicam recalls are unique to those particular products. However, they offer some insight into FDA's interpretation of a "serious adverse event" that must be reported to the agency. For example, FDA cites instances of elevated bilirubin levels, even when there are no symptoms associated with such increased levels, as a serious adverse event. It is arguable whether elevated bilirubin levels alone would have constituted a serious adverse event, however, were it not for the occurrence of several more serious liver-related events associated with Hydroxycut.

    FDA also appears to consider any loss of the sense of smell, even a temporary loss, to constitute a serious adverse event. This position may extend to other senses, such as taste. In general, FDA seems to place the onus on companies to determine whether an adverse event is "serious" not only in and of itself, but also in light of other reported adverse events.


    FDA Commissioner Sets Out Vision on Enforcement to Support Public Health



    In early August, FDA Commissioner Margaret Hamburg, MD, outlined her commitment "to prevent harm to the American people" through swift, aggressive and effective enforcement of FDA laws and regulations.

    "The FDA must be vigilant, the FDA must be strategic, the FDA must be quick, and the FDA must be visible," she told a group of industry representatives, attorneys, consumers, and others attending a speech sponsored by the Food and Drug Law Institute (FDLI), Washington, D.C. "We must get the word out that the FDA is on the job."

    Commissioner Hamburg said that some FDA enforcement actions over the past several years "have been hampered by unreasonable delays" and "in some cases, serious violations have gone unaddressed for far too long."

    Commissioner Hamburg highlighted six initial steps designed to hone the effectiveness and timeliness of the FDA's regulatory and enforcement system:

    Set post-inspection deadlines. The FDA will establish a clear timeline for regulated industry to respond to significant FDA inspection findings, generally giving no more than 15 days to respond to such findings before the agency issues a warning letter or takes other enforcement action.

    Take responsible steps to speed the warning letter process. The FDA will streamline the warning letter process by limiting review of warning letters by the Office of Chief Counsel to those that present significant legal issues.

    Work more closely with FDA's regulatory partners. In some cases, such as with food safety issues, state, local and international officials can act more quickly than the FDA. When public health is at risk, the agency will coordinate with its regulatory partners to take rapid action.

    Prioritize follow-up on warning letters and other enforcement actions. The FDA will work quickly to assess and follow up on corrective action taken by industry after a warning letter is issued or major product recall occurs.

    Be prepared to take immediate action in response to public health risks. To better protect the public health, the agency is prepared to act more quickly and aggressively to deal with significant public health concerns and violations. Such actions may occur before a formal warning letter is issued.

    Develop and implement a formal warning letter "close-out" process. If the agency can determine that a firm has fully corrected violations raised in a warning letter the agency will issue an official "close-out" notice and post this information on the FDA website. This will be an important motivator for corrective action by manufacturers.

    By taking these steps, Commissioner Hamburg said, the FDA will ensure that "violative inspection results are taken seriously, that warning letters and enforcement actions occur in a timely manner and that steps are taken to protect consumers in cases where immediate enforcement action is not possible."



    Related Searches
    • Quality & Safety
    • Testing
    • Regulations
    • Sports Nutrition
    Related Knowledge Center
    • Sports Nutrition
    • Dietary Supplements
    • Quality & Safety
    Suggested For You
    Poison Control Center Reports of Kids Ingesting Melatonin Rise by 530% Since 2012 Poison Control Center Reports of Kids Ingesting Melatonin Rise by 530% Since 2012
    Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized
    Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’ Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’
    FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products  FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products
    FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    Is There Momentum to Modernize DSHEA, or Too Much Division? Is There Momentum to Modernize DSHEA, or Too Much Division?
    NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act
    Ignore the Red Herrings: Myths & Facts about Mandatory Product Listing Ignore the Red Herrings: Myths & Facts about Mandatory Product Listing
    Dietary Supplement Listing Bill Introduced in Senate Dietary Supplement Listing Bill Introduced in Senate
    Dietary Supplement ‘Champion,’ and DSHEA Architect, Sen. Orrin Hatch Dies at 88 Dietary Supplement ‘Champion,’ and DSHEA Architect, Sen. Orrin Hatch Dies at 88
    Rhode Island Bill Would Restrict Sales of Weight Loss Supplements to Minors Rhode Island Bill Would Restrict Sales of Weight Loss Supplements to Minors
    U.S. Marshals Seize $1.3 Million Worth of Kratom in Florida U.S. Marshals Seize $1.3 Million Worth of Kratom in Florida
    2021 AHPA Awards Recognize Excellence in the Herbal Community 2021 AHPA Awards Recognize Excellence in the Herbal Community
    FDA Warns Against Male Enhancement and Weight Loss Products Sold Online FDA Warns Against Male Enhancement and Weight Loss Products Sold Online
    Understanding FTC Standards for Claims Substantiation Understanding FTC Standards for Claims Substantiation

    Related Online Exclusives

    • Infant & Children's Health | Quality & Safety
      Poison Control Center Reports of Kids Ingesting Melatonin Rise by 530% Since 2012

      Poison Control Center Reports of Kids Ingesting Melatonin Rise by 530% Since 2012

      While 1.6% of cases involved serious outcomes, the data gathered by these reports was limited and lacked medical data.
      By Mike Montemarano, Associate Editor 06.10.22

    • Dietary Supplements | Quality & Safety | Regulations
      Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’

      Safe & Accessible: Dietary Supplements Are Far From ‘Unregulated’

      With fewer recalls than conventional foods, drugs, animal products and medical devices, supplements could be considered the safest class of goods FDA regulates.
      By Michael McGuffin, President, American Herbal Products Association (AHPA) 06.02.22

    • Dietary Supplements | Mood Health & Sleep | Quality & Safety | Regulations
      Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized

      Dietary Supplements Are Regulated, and Chronic Stress Has Been Normalized

      As demand for health and nutrition products continues to grow in a world of hyper stress, it’s important to be clear about FDA’s regulatory authority.
      By Sean Moloughney, Editor 06.02.22


    • Breaking News | Dietary Supplements | Industry & Market News | Quality & Safety | Sports Nutrition
      FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products

      FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Products

      According to the agency, these products are promoted as hormone products or alternatives to anabolic steroids.
      05.18.22

    • Breaking News | Herbs & Botanicals | Industry & Market News | Quality & Safety | Regulations
      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      This marked the first time the agency took enforcement action against a delta-8 THC-containing product.
      05.04.22

    Trending
    • Three Grams Of Omega-3s May Be Optimal Dose For Reducing Blood Pressure
    • 3 grams of Omega-3s May be Optimal Dose for Reducing Blood Pressu
    • Olive/Pomegranate Extract May Improve Dyslipidemia
    Breaking News
    • Florida Food Products Acquires Javo
    • Roquette Launches Nutralys Rice Protein
    • New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy
    • CTRL Launches Meal On-The-Go Bars
    • GNC and RealEats Meal Delivery Partnership Expands Nationally
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges
    • Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Florida Food Products Acquires Javo
    Roquette Launches Nutralys Rice Protein
    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy
    Coatings World

    Latest Breaking News From Coatings World

    The Southern Society for Coatings Technology's 84th Annual Technical Conference A Success
    PPG to Showcase Specialty Automotive, Aerospace Adhesives, Sealants at Adhesives & Bonding Expo
    PPG’s New Paint for a New Start Initiative to Transform 25-plus Schools Worldwide
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Magnetic Insight Announces $17 Million in Series B Funding
    BreatheSuite Adds Brad Fluegel to its Board
    Labcorp Launches At-Home Collection Device for Diabetes Risk Testing
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pierre Fabre and Lonza Enter Manufacturing Agreement
    MasterControl and Elemental Machines Form Biomanufacturing Partnership
    Qosina Strengthens Aseptic Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Benefit Exec Joins Madison Reed's Board
    Peroni & Ellis Brooklyn Launch Fragrance Collection Inspired by Italian Spritz Cocktails
    Rhode Is Trending for June, Trendalytics Says
    Happi

    Latest Breaking News From Happi

    Botanical Embedded Candles Can Be Fire Hazard, Says National Candle Association
    Caire Beauty to Celebrate Menopause Empowerment Day
    Beautycounter Launches Text Campaign for FDA Safety and Landmark Advancements Act
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: INX’s VC Fund, Screen Industry and Ball Top This Week’s News
    British Coatings Federation Posts Online History
    Orion Announces Price Increases, Reduced Payment Terms
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PCMC teams with IGT, Fujifilm makes big announcement and more
    Loftware recognized as 'AIDC Company of the Year'
    Schreiner MediPharm highlights sustainability of Needle-Trap technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Tranzonic Names VP of Supply Chain
    Ontex Climate Action Targets Approved by Science-Based Targets Initiative
    Suominen Test Center Assesses Biodegradability of Nonwovens
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    3Spine Inc. Receives IDE Approval for U.S. Pivotal Clinical Trial
    Volume-Based Procurement to Reduce Chinese Orthopedic Market Value
    Isto Biologics Rolls Out Influx Fibrant
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: eMagin, Applied Materials, and Schott Top This Week’s Stories
    NREL Names Jennifer Logan to Leadership Team as CFO
    National Grid Renewables Orders 2 GW of First Solar Modules

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login